<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Head and Neck Cancer News</title>
<link>http://www.inboxrobot.com/news/head-and-neck-cancer</link>
<description>Constantly updated news and information about a variety of topics.</description><item>
<title>Merck working with cancer center on study</title>
<link>http://www.inboxrobot.com/news.php?fid=201402708</link>
<pubDate>2 Dec 2008 17:22 GMT</pubDate>
<description>
...  cancers and areas of unmet medical need. That list includes nonsmall cell lung cancer, head and neck cancer, pancreatic adenocarcinoma, and brain metastases from a solid tumor with an emphasis on lung  ...
</description>
</item><item>
<title>Merck working with National Comprehensive Cancer Network on research</title>
<link>http://www.inboxrobot.com/news.php?fid=201396513</link>
<pubDate>2 Dec 2008 16:57 GMT</pubDate>
<description>
...  cancers and areas of unmet medical need. That list includes nonsmall cell lung cancer, head and neck cancer, pancreatic adenocarcinoma, and brain metastases from a solid tumor with an emphasis on lung  ...
</description>
</item><item>
<title>Acupuncture beats aspirin</title>
<link>http://www.inboxrobot.com/news.php?fid=201387814</link>
<pubDate>2 Dec 2008 16:30 GMT</pubDate>
<description>
...  studies have shown that acupuncture helped alleviate pain in patients who had surgery for head and neck cancer, can relieve hot flashes and other menopausal symptoms and can reduce chemotherapy-induced nausea. (Reporting  ...
</description>
</item><item>
<title>Acupuncture Beats Aspirin for Chronic Headaches, Study Finds</title>
<link>http://www.inboxrobot.com/news.php?fid=201380063</link>
<pubDate>2 Dec 2008 15:33 GMT</pubDate>
<description>
...  studies have shown that acupuncture helped alleviate pain in patients who had surgery for head and neck cancer, can relieve hot flashes and other menopausal symptoms and can reduce chemotherapy-induced nausea. ...
</description>
</item><item>
<title>Combination Cancer Therapy is Focus of $1M Merck Research Grant Received by NCCN</title>
<link>http://www.inboxrobot.com/news.php?fid=201372116</link>
<pubDate>2 Dec 2008 14:51 GMT</pubDate>
<description>
...  combinations of vorinostat in selected locally advanced non-metastatic cancers including non-small cell lung cancer, head and neck cancer, pancreatic adenocarcinoma, and brain metastases from a solid tumor with an emphasis on lung  ...
</description>
</item><item>
<title>HAP Expands Medicare Advantage Options to Include Acupuncture and Chiropractic Services</title>
<link>http://www.inboxrobot.com/news.php?fid=201360711</link>
<pubDate>2 Dec 2008 13:50 GMT</pubDate>
<description>
...  of research suggests that acupuncture may help to ease some side effects of breast, head and neck cancer treatment; decrease the need for post-op painkillers; and relieve pain associated with osteoarthritis. To  ...
</description>
</item><item>
<title>Acupuncture beats aspirin for chronic headache</title>
<link>http://www.inboxrobot.com/news.php?fid=201287588</link>
<pubDate>2 Dec 2008 03:50 GMT</pubDate>
<description>
...  studies have shown that acupuncture helped alleviate pain in patients who had surgery for head and neck cancer, can relieve hot flashes and other menopausal symptoms and can reduce chemotherapy-induced nausea. (Reporting  ...
</description>
</item><item>
<title>PC Users Can Help Discover New Drugs to Treat AIDS &amp; Other Diseases</title>
<link>http://www.inboxrobot.com/news.php?fid=201281448</link>
<pubDate>2 Dec 2008 02:31 GMT</pubDate>
<description>
...  scientific research had begun. Help Defeat Cancer resulted in advanced therapies for breast, colon, head and neck cancer. These rapid developments would not have been achieved without the help of volunteer PC  ...
</description>
</item><item>
<title>Curbing hormones&#39; effects in obese patients could aid against breast cancer</title>
<link>http://www.inboxrobot.com/news.php?fid=201257102</link>
<pubDate>1 Dec 2008 23:31 GMT</pubDate>
<description>
...  inhibitors, such as erlotinib and cetuximab, have been approved by the FDA to treat head and neck cancer, lung cancer, colon cancer and pancreatic cancer. One, lapatinib, was approved in 2007 for  ...
</description>
</item><item>
<title>Introgen Restructures Operations to Focus on Revenue-Generating Manufacturing Capabilities</title>
<link>http://www.inboxrobot.com/news.php?fid=201162247</link>
<pubDate>1 Dec 2008 14:54 GMT</pubDate>
<description>
...  and treatment resistance. ADVEXIN has demonstrated increased survival and tumor growth control in recurrent head and neck cancer patients. ADVEXIN has demonstrated clinical activity in a number of solid tumor types in  ...
</description>
</item><item>
<title>Merck KGaA gets expanded approval for Erbitux in Europe</title>
<link>http://www.inboxrobot.com/news.php?fid=201145035</link>
<pubDate>1 Dec 2008 13:05 GMT</pubDate>
<description>
...  to treat cancers, he added. Merck noted that there are around 143,000 cases of head and neck cancer in Europe, and more than 68,000 deaths due to the disease, each year. About  ...
</description>
</item><item>
<title>European Commission Approves Erbitux for First-Line Use in Head and Neck Cancer</title>
<link>http://www.inboxrobot.com/news.php?fid=201144793</link>
<pubDate>1 Dec 2008 13:05 GMT</pubDate>
<description>
...  each year.2 About 40% of patients with head and neck cancer have recurrent and/or metastatic SCCHN.3 Head and  ...  growth factor receptor (EGFR). About 90% of head and neck cancers are of the squamous cell variety5 and  ...
</description>
</item><item>
<title>Merck Serono: European Commission Approves Erbitux For 1st-Line Use In Head And Neck Cancer</title>
<link>http://www.inboxrobot.com/news.php?fid=201134506</link>
<pubDate>1 Dec 2008 11:32 GMT</pubDate>
<description>
Merck Serono, a division of Merck KGaA, announced today that it has received approval from the European Commission to extend the use of its targeted  ...
</description>
</item><item>
<title>NIH designation lifts UMMC cancer research</title>
<link>http://www.inboxrobot.com/news.php?fid=201091661</link>
<pubDate>1 Dec 2008 06:11 GMT</pubDate>
<description>
...  team is analyzing social and genetic factors that may explain why blacks diagnosed with head and neck cancer have a less-than-favorable prognosis than their white counterparts. During the NCI&amp;rsquo;s selection process, these  ...
</description>
</item><item>
<title>Cel-Sci lets Teva sell cancer drug</title>
<link>http://www.inboxrobot.com/news.php?fid=201056534</link>
<pubDate>30 Nov 2008 22:51 GMT</pubDate>
<description>
...  evenly between both companies. The licensing agreement is initially restricted to the areas of head and neck cancer. Teva has the rights, subject to certain conditions, to extend the licensing agreement to  ...
</description>
</item></channel>
</rss>
